Industry Insights: MedComms 24 October
In this piece, we spotlight three issues in the publishing world that are driving conversations within the industry. We look at inaccurate author disclosures in medical publishing, delve into the open access debate, and discuss the art of crafting suitable lay titles for clinical trials. The problem of unreliable author disclosures persists in the medical […]
Industry Insights: MedComms 2 October
Here we cover three hot topics in publishing that are shaping the industry dialogue. We focus on BioGPT: a generative AI model that generates fluent descriptions for biomedical terms, why there is a call to reform the current scholarly publishing model, and using the patient voice in publishing. As generative AI models like BioGPT and […]
Industry Insights: MedComms 18 September
With the ongoing pressure in the academic world to publish, the term ‘Publish or Perish’ is well known. Here we cover three important and related topics in the industry. We look at the use of embellished language (hyperbolic adjectives) in scientific writing, and publishing in predatory as well as open access (OA) journals. In recent […]
Industry Insights: MedComms 4th of September
Here we examine three hot topics in medical writing that are shaping the industry dialogue. We take a look at the impact of retracted scientific articles, the advantages of using artificial intelligence (AI) in text creation, and the ban by Nature on the use of AI-generated visual content in its journals. There is increasing concern […]
